In Charles Bonnet syndrome an individual with impaired vision experiences visual hallucinations, often of a complex nature. The syndrome is named after the 18th century naturalist and philosopher who described these symptoms in his grandfather. In 1936 Morsier proposed including under the label those visual hallucinations occurring in the elderly who had preservation of intellectual function and thus insight into the nature of the visions1. Since then many cases have been described in association with established eye disease; here we describe a case in which Charles Bonnet syndrome was the presenting feature of type II diabetes mellitus.
CASE HISTORY
A woman aged 72 reported recent onset of right-sided headaches. Apart from angina treated with atenolol her medical history was unremarkable. The headaches were associated with difficulty in focusing on objects and consequent clumsiness in her actions. They resolved within a week but were succeeded by visual hallucinations of a man and woman in outline 'tumbling' towards her. She was unable to discern facial features or describe colours but they were plainly located in external space and present throughout her waking day. These visions persisted and she soon became used to them, describing them as part of life.
A psychiatric assessment and mental state examination including cognitive assessment revealed nothing out of the ordinary, apart from the hallucinations. A computed tomographic scan and an electroencephalogram were reported normal and Charles Bonnet syndrome was diagnosed. Carbamazepine is reported useful in this disorder2 and was started at 200mg twice daily.
As her vision remained blurred she visited her optician who noted that her visual acuity had deteriorated greatly since her previous test. New lenses were prescribed and she was advised to have her blood glucose measured, which proved to be 19.0 mmol/L (random). Type II diabetes was diagnosed and she was started on glibenclamide. In retrospect she said that polyuria and polydipsia had developed at the time of onset of the hallucinations.
At review six months later the hallucinations had become much less frequent and were of a more shadowy nature, giving the impression of a dog or cat passing on the right; she also occasionally saw a swarm of flies in front of her. An ophthalmologist judged that her visual difficulties were due to hyperglycaemia-related alteration in the shape of the lens; there was no evidence of diabetic retinal disease although some minor hypertensive changes were present. With improvement in her blood glucose her visual acuity had improved and she had resumed wearing her old glasses. COMMENT Teunisse and co-workers3, in the Netherlands, found an 1 1% prevalence of Charles Bonnet syndrome in people with low visual acuity. Like others they found an increasing incidence with age. There is a growing consensus that the syndrome results from visual sensory deprivation4. If so, we might have expected our patient's hallucinations to resolve when vision improved-especially since diabetic retinopathy, more commonly associated with Charles Bonnet syndrome5, was absent. Advanced age in the absence of visual impairment has been associated with the syndrome3 and we surmise that small-vessel cerebrovascular damage associated with diabetes could have compounded an age related process. Impairment of the visual system must be considered when elderly patients present with visual hallucinations, particularly if insight is present. A blood glucose may prove a fruitful investigation.
